⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18654060 | 0.83 | ALDH1A1 (0.32) | — | |
| SCHEMBL18650577 | 0.77 | — | — | |
| SCHEMBL29229981 | 0.75 | RIPK1 (0.39) | — | |
| SCHEMBL1555324 | 0.74 | — | — | |
| SCHEMBL2876205 | 0.74 | — | — | |
| SCHEMBL13684603 | 0.74 | TSHR (0.31) | — | |
| SCHEMBL24985018 | 0.72 | — | — | |
| SCHEMBL1935820 | 0.72 | — | — | |
| SCHEMBL11200039 | 0.72 | — | — | |
| SCHEMBL18654094 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11964060-B2 | Nicotine-containing transparent transdermal therapeutic system | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2024-04-23 | — | — | US | disclosed |
| CN-117858910-A | Copolymer, piezoelectric material, piezoelectric film, and piezoelectric element | TDK株式会社 | 2024-04-09 | — | — | CN | disclosed |
| US-20230387464-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-11-30 | — | — | US | disclosed |
| US-20230125746-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| WO-2023032614-A1 | COPOLYMER, PIEZOELECTRIC MATERIAL, PIEZOELECTRIC FILM, AND PIEZOELECTRIC ELEMENT | TDK株式会社 | 2023-03-09 | — | — | WO | disclosed |
| CN-115458614-A | Use of electrical conductors in solar cells | 路美特技术有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-109565935-B | Use of electrical conductors in solar cells | 路美特技术有限公司 | 2022-09-06 | — | — | CN | disclosed |
| US-20220241466-A1 | DEGRADABLE POLYMERIC TISSUE SCAFFOLD | MOSAIC BIOSCIENCES INC (US) | 2022-08-04 | — | — | US | disclosed |
| EP-4012814-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTIC-SOLUTION BATTERY | Mitsubishi Chemical Corporation (JP) | 2022-06-15 | — | — | EP | disclosed |
| US-20220158244-A1 | Nonaqueous Electrolyte Solution and Nonaqueous-Electrolytic-Solution Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-19 | — | — | US | disclosed |
| WO-2007140479-A1 | PRODUCTION OF METAL NANOPARTICLES FROM PRECURSORS HAVING LOW REDUCTION POTENTIALS | CABOT CORPORATION (US) | 2007-12-06 | — | — | WO | disclosed |
| WO-2006076611-A2 | PRODUCTION OF METAL NANOPARTICLES | CABOT CORPORATION (US) | 2006-07-20 | — | — | WO | disclosed |
| WO-2006076612-A2 | A PROCESS FOR MANUFACTURING APPLICATION SPECIFIC PRINTABLE CIRCUITS (ASPC’S) AND OTHER CUSTOM ELECTRONIC DEVICES | CABOT CORPORATION (US) | 2006-07-20 | — | — | WO | disclosed |
| WO-2006076613-A2 | METAL NANOPARTICLE COMPOSITIONS | CABOT CORPORATION (US) | 2006-07-20 | — | — | WO | disclosed |
| WO-2006076603-A2 | PRINTABLE ELECTRICAL CONDUCTORS | CABOT CORPORATION (US) | 2006-07-20 | — | — | WO | disclosed |
| EP-0122453-A1 | Process for the preparation of polyhydroxy compounds which contain blocked and optionally free hydroxy groups, polyhydroxy compounds obtained by this process and coating compositions based on these polyhydroxy compounds | BAYER AG (DE) | 1984-10-24 | — | — | EP | disclosed |
| US-4391980-A | FOR INVERSION OF CONFIGURATION OF OPTICALLY ACTIVE COMPOUNDS | CIBA-GEIGY CORPORATION (US) | 1983-07-05 | — | — | US | disclosed |
| EP-0007605-B1 | A PROCESS FOR INVERTING THE CONFIGURATION IN OPTICALLY ACTIVE COMPOUNDS AND OPTICALLY ACTIVE INTERMEDIATE COMPOUNDS AND THEIR SALTS REQUIRED THEREFOR | CIBA-GEIGY AG (CH) | 1982-09-15 | — | — | EP | disclosed |
| US-4294966-A | SALT FORMATION | CIBA-GEIGY CORPORATION (US) | 1981-10-13 | — | — | US | disclosed |
| US-4161530-A | CYCLIC SUBSTITUTED AMINO ALCOHOL BETA-RECEPTOR-BLOCKING AGENT AND TRYPTOPHANE | CIBA-GEIGY CORPORATION (US) | 1979-07-17 | — | — | US | disclosed |